Last --
Change Today 0.00 / 0.00%
Volume 0.0
1066 On Other Exchanges
Symbol
Exchange
1066 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

shandong weigao gp medical-h (1066) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SHANDONG WEIGAO GP MEDICAL-H (1066)

Related News

No related news articles were found.

shandong weigao gp medical-h (1066) Related Businessweek News

No Related Businessweek News Found

shandong weigao gp medical-h (1066) Details

Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of medical devices under the Jierui and Wego Ortho brands in the People’s Republic of China and internationally. The company operates through Single Use Medical Device Products, Orthopaedic Products, and Blood Purification Products divisions. It offers single use medical consumables and materials, which include infusion sets, syringes, blood bags and blood component segregator consumables, blood sampling consumables, pre-filled syringes, dental consumables, anesthetic consumables, and medical PVC granules and non-PVC granules, as well as medical needle products comprising intravenous, syringe, intravenous catheter, blood sampling, and irregular needles. The company also provides orthopaedic materials and tools comprising therapeutic consumables, such as steel plates, screws, spinal series consumables, and artificial joints consumables. In addition, it offers blood purification consumables, including renal consumables, such as puncture needles, blood circuits, dialysis equipment, and immunity adsorption products for the treatment of immune system diseases; and other LDL adsorption, internal toxin adsorption, and hepatitis B adsorption products, as well as heart eluting stents, including drug eluting stents and balloon catheters. Further, the company is involved in trading medical products; providing logistics and storage services; and manufacturing moulds, and industrial automatic equipment and parts, as well as provides medical management software development and related technical consulting services. It sells its products to healthcare organizations and distributors, including hospitals, blood stations, and other medical units. The company was founded in 2000 and is based in Weihai, the People’s Republic of China. Shandong Weigao Group Medical Polymer Company Limited is a subsidiary of Weigao Holding Company Limited.

9,304 Employees
Last Reported Date: 04/8/14
Founded in 2000

shandong weigao gp medical-h (1066) Top Compensated Officers

Vice Chairman, General Manager, Compliance Of...
Total Annual Compensation: CNY1.2M
Executive Director
Total Annual Compensation: CNY900.0K
Executive Director
Total Annual Compensation: CNY666.0K
Deputy General Manager of General Affairs and...
Total Annual Compensation: CNY954.0K
Supervisor
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

shandong weigao gp medical-h (1066) Key Developments

Shandong Weigao Group Medical Polymer Co., Limited Presents at Hong Kong and China Corporate Day (Theme: Healthcare) 2014, Jul-08-2014

Shandong Weigao Group Medical Polymer Co., Limited Presents at Hong Kong and China Corporate Day (Theme: Healthcare) 2014, Jul-08-2014 . Venue: Island Shangri-la Hotel, Hong Kong.

Shandong Weigao Group Medical Polymer Co., Limited Approves Final Dividend for the Year Ended December 31, 2013

Shandong Weigao Group Medical Polymer Co., Limited announced that at its AGM held on May 30, 2014, approved to authorize the board for the distribution of the final dividends of RMB 0.031 per share of RMB 0.1 each in the company for the year ended December 31, 2013.

Shandong Weigao Group Medical Polymer Co. Ltd. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

Shandong Weigao Group Medical Polymer Co. Ltd. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenue of RMB 1,168,024 million compared to RMB 1,012,676 million a year ago. Profit before taxation was RMB 253,934 million compared to RMB 260,655 million a year ago. Profit for the period attributable to equity holders of the company was RMB 215,954 million or RMB 0.048 per basic share compared to RMB 228,322 million or RMB 0.051 per basic share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1066:HK $7.80 HKD -0.07

1066 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1066.
View Industry Companies
 

Industry Analysis

1066

Industry Average

Valuation 1066 Industry Range
Price/Earnings 76.6x
Price/Sales 6.0x
Price/Book 3.2x
Price/Cash Flow 76.6x
TEV/Sales 5.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG WEIGAO GP MEDICAL-H, please visit www.weigaogroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.